NRIX
Price
$16.85
Change
+$0.90 (+5.64%)
Updated
Feb 6 closing price
Capitalization
1.73B
65 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$10.60
Change
+$0.53 (+5.26%)
Updated
Feb 6 closing price
Capitalization
405.12M
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs TRDA

Header iconNRIX vs TRDA Comparison
Open Charts NRIX vs TRDABanner chart's image
Nurix Therapeutics
Price$16.85
Change+$0.90 (+5.64%)
Volume$836.57K
Capitalization1.73B
Entrada Therapeutics
Price$10.60
Change+$0.53 (+5.26%)
Volume$192.21K
Capitalization405.12M
NRIX vs TRDA Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. TRDA commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (NRIX: $16.85 vs. TRDA: $10.60)
Brand notoriety: NRIX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 53% vs. TRDA: 89%
Market capitalization -- NRIX: $1.73B vs. TRDA: $403.98M
NRIX [@Biotechnology] is valued at $1.73B. TRDA’s [@Biotechnology] market capitalization is $403.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both NRIX and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • NRIX’s TA Score: 3 bullish, 5 bearish.
  • TRDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both NRIX and TRDA are a bad buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а +2.00% price change this week, while TRDA (@Biotechnology) price change was -7.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

NRIX is expected to report earnings on Apr 14, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.73B) has a higher market cap than TRDA($405M). TRDA YTD gains are higher at: 3.113 vs. NRIX (-11.176). TRDA has higher annual earnings (EBITDA): -117.36M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. TRDA (327M). TRDA has less debt than NRIX: TRDA (52.4M) vs NRIX (56.5M). NRIX has higher revenues than TRDA: NRIX (83.7M) vs TRDA (61.5M).
NRIXTRDANRIX / TRDA
Capitalization1.73B405M428%
EBITDA-248.7M-117.36M212%
Gain YTD-11.1763.113-359%
P/E RatioN/A10.26-
Revenue83.7M61.5M136%
Total Cash429M327M131%
Total Debt56.5M52.4M108%
TECHNICAL ANALYSIS
Technical Analysis
NRIXTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSLVX51.612.15
+4.35%
Hartford Small Cap Growth R6
PFPMX40.691.09
+2.75%
Parnassus Mid Cap Institutional
BUFIX25.000.57
+2.33%
Buffalo International
ACETX11.420.14
+1.24%
Invesco Equity and Income Y
HSUAX37.740.37
+0.99%
Rational Dynamic Brands A

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+5.64%
KYMR - NRIX
72%
Closely correlated
+4.81%
RVMD - NRIX
70%
Closely correlated
+1.39%
SYRE - NRIX
70%
Closely correlated
+6.62%
IMNM - NRIX
70%
Closely correlated
+3.67%
TRDA - NRIX
69%
Closely correlated
+5.26%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with CGEM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+5.26%
CGEM - TRDA
75%
Closely correlated
+3.21%
IPSC - TRDA
75%
Closely correlated
+1.80%
TERN - TRDA
74%
Closely correlated
+6.88%
STRO - TRDA
73%
Closely correlated
+6.30%
ATOS - TRDA
72%
Closely correlated
+0.19%
More